| Bioactivity | Faralimomab (64G12) is an immunomodulator, and a murine anti-IFNA1 IgG1 mAb[1]. |
| Target | IFNA1 |
| Name | Faralimomab |
| CAS | 167816-91-3 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Pelletier J P R, et al. Passive monoclonal and polyclonal antibody therapies[M]//Immunologic Concepts in Transfusion Medicine. Elsevier, 2020: 251-348. |